Clinical Trial Update: Finerenone and Cardiac Remodeling [Phase 3]

View source ↗

Summary

A Phase 3 trial update for finerenone investigating its effects on cardiac remodeling in heart failure. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Kerendia (finerenone)

Snippet

Sponsor: Subodh Verma | Conditions: Heart Failure | Phase 3 | Status: NOT_YET_RECRUITING